胰岛素帮浦市场规模、份额、成长分析、按产品类型、按配件、按最终用途、按地区 - 行业预测，2024-2031 年

2022年全球胰岛素帮浦市场规模预计为55.9亿美元，从2023年的60.5亿美元成长到2031年的113.8亿美元，预测期（2024-2031）预计复合年增长率为8.22%。

胰岛素帮浦市场正在经历显着成长，这主要是由于全球范围内糖尿病（尤其是第 1 型糖尿病）盛行率上升所推动。 2019年，糖尿病患者人数估计为5.37亿，预计2045年将达到7.83亿人。随着领先的医疗设备製造商不断创新并推出整合了人工智慧 (AI) 和机器学习 (ML) 等功能的先进胰岛素泵，技术进步也对这一激增进行了补充。这些发展不仅改善了使用者体验，也提高了治疗效果。人们对糖尿病管理和治疗方案的认识不断增强，加上医疗保健成本不断上升以及医疗设施的改善，使得胰岛素帮浦市场将经历快速成长。此外，预计未来几年将保持强劲的复合年增长率，这反映了美国市场的情况。这些技术创新和不断增长的医疗保健需求相结合，凸显了胰岛素帮浦市场的巨大潜力，使其成为糖尿病护理解决方案投资和市场开拓的焦点。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• PESTEL分析
• 技术分析
• 价格分析
• 供应链分析

胰岛素帮浦市场：按类型

• 市场概况
• 贴片帮浦
• 繫绳帮浦

胰岛素帮浦市场：副产品

• 市场概况
• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• 其他的

胰岛素帮浦市场：依配件分类

• 市场概况
• 胰岛素储液器或药筒
• 胰岛素套插入装置
• 电池

胰岛素帮浦市场：依最终用途分类

• 市场概况
• 医院/诊所
• 居家照护
• 研究所

胰岛素帮浦市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Medtronic（Ireland）
• Hoffmann-La Roche AG（Switzerland）
• Tandem Diabetes Care, Inc.（US）
• Insulet Corporation（US）
• Ypsomed AG（Switzerland）
• Sanofi SA（France）
• Sooil Development（Korea）
• Jiangsu Delfu Co., Ltd.（China）
• Cellnovo Ltd.（UK）
• Valeritas, Inc.（US）
• Debiotech SA（Switzerland）
• CeQur Simplicity（Switzerland）
• Microtec Medical Ltd.（UK）
• ViCentra BV（Netherlands）
• EOFLOW CO., LTD.（Korea）
• Becton, Dickinson and Company（US）
• Abbott Laboratories（US）
• Braun Melsungen AG（Germany）
• Animus Corporation（US）
• Asante（US）
• Nipro Diagnostic, Inc.（Japan）

Global Insulin Pump Market size was valued at USD 5.59 billion in 2022 and is poised to grow from USD 6.05 billion in 2023 to USD 11.38 billion by 2031, growing at a CAGR of 8.22 % in the forecast period (2024-2031).

The insulin pump market is experiencing significant growth, driven primarily by the rising prevalence of diabetes, especially type 1 diabetes, on a global scale. With an estimated 537 million individuals living with diabetes in 2019-a figure projected to reach 783 million by 2045-there is an increasing demand for portable insulin delivery systems among patients. This surge is complemented by advancements in technology, as leading medical device manufacturers innovate and release sophisticated insulin pumps integrated with features like artificial intelligence (AI) and machine learning (ML). These developments not only enhance user experience but also improve treatment efficacy. As awareness of diabetes management and treatment options expands, coupled with the escalation in healthcare costs and improved access to medical facilities, the market for insulin pumps is positioned for rapid growth. Furthermore, the U.S. insulin pump market is expected to sustain a robust compound annual growth rate (CAGR) in the upcoming years, reflecting a healthy market landscape. This combination of technological innovation and increasing healthcare demands underscores the insulin pump market's promising potential, making it a focal point for investment and development in diabetes care solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pump Market Segmental Analysis

Global Insulin Pump Market is segmented on the basis of type, product, accessories, end use, and region. By type, market is segmented into patch pumps, and tethered pumps. By product, market is segmented into MiniMed, Accu-Chek, Tandem, Omnipod, and others. By accessories, market is segmented into insulin reservoir or cartridges, insulin set insertion devices, and battery. By End use, market is segmented into hospitals & clinics, homecare, and laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Insulin Pump Market

The growing adoption of insulin pumps among diabetic patients, both in developed and emerging markets, serves as a significant driver for the global insulin pump market. Market participants are increasingly focusing their research and development efforts on innovative, technologically advanced products to meet this rising demand. The positive outcomes from various clinical trials highlighting improved glucose control in type 2 diabetes patients utilizing pump therapy versus those on Multiple Daily Injection (MDI) therapy further boost market prospects. As patients and healthcare providers seek superior diabetes management solutions, the continuous advancement and introduction of new insulin delivery devices will enhance market growth, fostering improved patient outcomes.

Restraints in the Global Insulin Pump Market

The Global Insulin Pump market faces significant restraints primarily due to limited reimbursement options and the high costs associated with insulin pumps, making them less accessible for patients who heavily rely on financial support for treatment. This is particularly pronounced in underdeveloped and emerging countries, where awareness of diabetes and insulin pump technologies is low, stemming from inadequate healthcare infrastructure. The International Diabetes Federation reported that approximately 232 million diabetics were undiagnosed in 2019, further complicating market penetration. As a result, these financial and awareness barriers hinder the widespread adoption of insulin pump technologies, potentially stalling market growth.

Market Trends of the Global Insulin Pump Market

The Global Insulin Pump market is poised for significant growth, driven by the integration of intelligent technologies such as AI into healthcare IT. This advancement facilitates the development of AI-enabled insulin pumps and automated drug delivery systems, particularly tailored for type 2 diabetes management. As the prevalence of type 2 diabetes continues to rise, there is an increasing demand for technologically advanced insulin pumps, with current adoption rates hovering around 5% and projected to reach approximately 15% by 2027. This shift reflects a broader trend towards innovation in diabetes care, positioning the insulin pump market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• PESTEL Analysis
• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis

Insulin Pump Market, By Type

• Market Overview
• Patch pumps
• Tethered pumps

Insulin Pump Market, By Product

• Market Overview
• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• Others

Insulin Pump Market, By Accessories

• Market Overview
• Insulin reservoir or cartridges
• Insulin set insertion devices
• Battery

Insulin Pump Market, By End Use

• Market Overview
• Hospitals & clinics
• Homecare
• Laboratories

Insulin Pump Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sooil Development (Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Delfu Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellnovo Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeritas, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Debiotech S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CeQur Simplicity (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microtec Medical Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViCentra B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EOFLOW CO., LTD. (Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animus Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asante (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Diagnostic, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments